col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


32 Results       Page 1

 [1] 
American Thoracic Society: American Journal of Respiratory Cell and Molecular Biology
  original article Date Title Authors   All Authors
1 [GO] 2022―Jun―08 Insights from Transcriptomics: CD163+ Profibrotic Lung Macrophages in COVID-19 Mallar Bhattacharya
2 [GO] 2022―Apr―06 Persistently Elevated Plasma Levels of RIPK3, MLKL, HMGB1, and RIPK1 in COVID-19 ICU Patients Katharina Ruskowski, Holger Neb, Steven R Talbot, Suma Choorapoikayil, Elisabeth H Adam, Andreas von Knethen, et al. (+2)
3 [GO] 2022―Apr―01 Expression of ACE2 - A Key SARS-CoV-2 Entry Factor - Is Not Increased in the Nasal Mucosa of People with Cystic Fibrosis Marc A Sala, Nikolay S Markov, Yuliya Politanska, Hiam Abdala-Valencia, Alexander V. Misharin, Manu Jain
4 [GO] 2022―Mar―29 COVID-19 and Long-Term Outcomes: Lessons from Other Critical Care Illnesses and Potential Mechanisms Eli Arbov, Alia Tayara, Songwei Wu, Thomas C. Rich, Brant M. Wagener
5 [GO] 2022―Jan―27 IL-13 Protects Against SARS-CoV-2? R. Stokes Peebles Jr.
6 [GO] 2022―Jan―04 The Type 2 Asthma Mediator IL-13 Inhibits SARS-CoV-2 Infection of Bronchial Epithelium Luke R Bonser, Walter L. Eckalbar, Lauren Rodriguez, Jiangshan Shen, Kyung Duk Koh, Khadija Ghias, et al. (+5)
7 [GO] 2021―Nov―10 Understanding COVID-19 Pathophysiology - What Defines Progress? Grant Waterer
8 [GO] 2021―Nov―10 Differences Between Children and Adults with COVID-19: It’s Right Under our Nose Eric D Morrell, Carmen Mikacenic
9 [GO] 2021―Nov―03 Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2 Clarissa M Koch, Andrew D Prigge, Kishore R Anekalla, Avani Shukla, Hanh Chi Do Umehara, Leah Setar, et al. (+12)
10 [GO] 2021―Oct―28 Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19 Clark D Russell, Asta Valanciute, Naomi N Gachanja, Jillian Stephen, Rebekah Penrice-Randal, Stuart D Armstrong, et al. (+13)
11 [GO] 2021―Oct―14 Evidence that SARS-CoV-2 Induces Lung-Cell Senescence: Potential Impact on COVID-19 Lung Disease Larissa Lipskaia, Pauline Maisonnasse, Charles Fouillade, Valentin Sencio, Quentin Pascal, Jean-Michel Flaman, et al. (+6)
12 [GO] 2021―Jul―09 Erratum: Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection
13 [GO] 2021―Jun―04 The Central Role of Plasminogen Activator Inhibitor-1 in COVID-19: Thrombosis and Beyond Sadiya S Khan
14 [GO] 2021―May―18 ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial Plasminogen Activator Inhibitor-1 Mingming Han, Deepesh Pandey
15 [GO] 2021―May―10 SARS-CoV-2 Infection is Associated with Reduced Krüppel-Like Factor 2 in Human Lung Autopsy David Wu, Tzu-Han Lee, Ru-Ting Huang, Rob Guzy, Nathan Schoettler, Ayodeji Adegunsoye, et al. (+5)
16 [GO] 2021―Apr―02 The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness Stephen J. Kuperberg, Brianne Navetta-Modrov
17 [GO] 2021―Mar―30 Clotting in COVID-19: Is It All in the Genes? Ana I Hernandez Cordero, Don D Sin
18 [GO] 2021―Mar―30 A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples Taruna Madan, Barnali Biswas, Praveen M. Varghese, Rambhadur Subedi, Hrishikesh Pandit, Susan Idicula-Thomas, et al. (+8)
19 [GO] 2021―Mar―26 COVID-19 and Coagulopathy Ken-ichiro Inoue, Tomoya Sagawa, Hirohisa Takano
20 [GO] 2021―Mar―26 Reply to: COVID-19 and Coagulopathy Cristina Rodríguez, Neus Luque, Isabel Blanco, Laura Sebastian, Joan Albert Barberà, Víctor I Peinado, Olga Tura-Ceide
21 [GO] 2021―Mar―19 Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19 Associated Coagulopathies Ethan S. FitzGerald, Yongzhi Chen, Katherine A. Fitzgerald, Amanda M. Jamieson
22 [GO] 2020―Dec―09 Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges Hongpeng Jia, Enid Neptune, Honggang Cui
23 [GO] 2020―Nov―12 Pulmonary Endothelial Dysfunction and Thrombotic Complications in COVID-19 Patients Cristina Rodríguez, Neus Luque, Isabel Blanco, Laura Sebastian, Joan Albert Barberà, Víctor I. Peinado, Olga Tura-Ceide
24 [GO] 2020―Nov―10 Rapidly Deployable Mouse Models of SARS-CoV-2 Infection Add Flexibility to the COVID-19 Toolbox James A Harker, Cecilia Johansson
25 [GO] 2020―Sep―29 Lung Expression of Human ACE2 Sensitizes the Mouse to SARS-CoV-2 Infection Kun Han, Robert V Blair, Naoki Iwanaga, Fengming Liu, Kasi E Russell-Lodrigue, Zhongnan Qin, et al. (+19)
26 [GO] 2020―Sep―18 Effects of Asthma and Human Rhinovirus A16 on the Expression of the SARS-CoV-2 Entry Factors in Human Airway Epithelium Ryan C Murphy, Ying Lai, Kaitlyn A Barrow, Jessica A. Hamerman, Adam Lacy-Hulbert, Adrian M Piliponsky, et al. (+5)
27 [GO] 2020―Sep―08 Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2 Infected Hamsters - What Matters? Achim D Gruber, Nikolaus Osterrieder, Luca D Bertzbach, Daria Vladimirova, Selina Greuel, Jana Ihlow, et al. (+3)
28 [GO] 2020―Aug―28 Azithromycin Downregulates Gene Expression of IL-1β and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2 Axel E. Renteria, Leandra Endam Mfuna, Damien Adam, Ali Filali-Mouhim, Anastasios Maniakas, Simon Rousseau, et al. (+3)
29 [GO] 2020―Aug―04 COVID-19: Clean up on IL-6 Tanner L Hedrick, Brian P Murray, Robert S. Hagan, Jason R Mock
30 [GO] 2020―Jul―24 Inducible Epithelial Resistance Against Coronavirus Pneumonia in Mice Scott E Evans, Chien-Te K. Tseng, Brenton L. Scott, A. Magnus Höök, Burton F Dickey
31 [GO] 2020―Jun―23 Metabolomics to Predict Antiviral Drug Efficacy in COVID-19 Marie Migaud, Sheetal Gandotra, Hitendra S. Chand, Mark N. Gillespie, Victor J Thannickal, Raymond J Langley
32 [GO] 2020―Apr―21 A Call for Rational Intensive Care in the Era of COVID-19 Benjamin D Singer, Manu Jain, G.R. Scott Budinger, Richard G Wunderink
 [1] 

32 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec